Please use this identifier to cite or link to this item:
DC FieldValue
dc.titlePRL-3 promotes epithelial-mesenchymal transition and confers resistance to apoptosis
dc.contributor.authorSAMANTHA QUAH YILING
dc.identifier.citationSAMANTHA QUAH YILING (2010-01-16). PRL-3 promotes epithelial-mesenchymal transition and confers resistance to apoptosis. ScholarBank@NUS Repository.
dc.description.abstractPRL-3 is a multi-tasking phosphatase involved in cancer metastasis. It promotes various cancer-related properties, such as motility, invasiveness and tumorigenicity. Two important features of cancer progression are Epithelial-Mesenchymal Transition (EMT) and evasion of programmed cell death. EMT is a process that is important for embryonic development and oncogenesis. This process causes epithelial cells to adopt a migratory mesenchymal phenotype. Evasion of apoptosis allows transformed cells to survive in the circulation to reach distant secondary sites. Here we attempt to understand the role of PRL-3 in these two processes. In this study, we found that cells expressing PRL-3 exhibited reduced focal adhesion proteins paxillin, phosphorylated paxillin-Tyr31 and vinculin. Additionally, there was reduction in RhoA-GTP, Racl-GTP and filamentous-actin (F-actin). DLD-1 human colorectal cancer cells stably expressing EGFP-PRL-3 showed activation of Akt by PRL-3 and inactivation of glycogen synthase kinase-3?. In these cells, PRL-3 also down-regulated epithelial markers E-cadherin, gamma-catenin (plakoglobin) and integrin ?3 while up-regulating mesenchymal markers fibronectin and snail. These changes could all be abrogated by the phophoinositide 3-kinase (PI3K) inhibitor LY294002. Thus PRL-3 would act upstream of PI3K to initiate EMT during cancer metastasis. PRL-3 also down-regulates phosphatase and tensin homologue deleted on chromosome 10 (PTEN), which is a key antagonist of PI3K, reinforcing PI3K/Akt activation. These changes point to PRL-3 promoting EMT by signalling through PI3K and down-regulating PTEN. Activation of Akt is also known to have effects on cell cycle regulation and cell survival. We found that MCF7 cells and DLD-1 cells stably expressing EGFP-PRL-3 were more resistant to genotoxic agents methyl methanesulfonate (MMS) and doxorubicin, as well as oxidative stress induced by H2O2. We screened protein lysates from these cells using a commercial antibody array to find cell cycle related proteins whose phosphorylation status could be modified by PRL-3, and for proteins that could interact with PRL-3. We identified the Growth Arrest and DNA Damage protein GADD34 as a candidate that fulfils both conditions consistently across different cell lines. To understand how PRL-3 could mediate GADD34 phosphorylation, we looked for changes in Lyn, a Src family kinase known to phosphorylated GADD34 and negatively regulate its pro-apoptotic response to genotoxic apoptosis. Surprisingly, we found that PRL-3 down-regulated Lyn protein as well as mRNA. We take this finding to indicate that PRL-3 might promote phosphorylation of GADD34 by an alternative pathway that is independent of Lyn. These events require PRL-3 phosphatase activity, as the catalytically inactive mutant PRL-3 (C104S) could not effect these changes. We propose that PRL-3 confers resistance to apoptosis through phosphorylation and inhibition of GADD34. These findings are part of the growing body of evidence that PRL-3 is a multi-tasking phosphatase involved in cancer metastasis through a variety of processes. PRL-3 is thus a promising molecular target for cancer therapy.
dc.subjectPRL-3, PTEN, AKT, EMT, GADD34, Apoptosis
dc.contributor.supervisorZENG QI
dc.description.degreeconferredMASTER OF SCIENCE
Appears in Collections:Master's Theses (Open)

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
QuahYS.pdf1.84 MBAdobe PDF



Page view(s)

checked on May 22, 2019


checked on May 22, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.